Name | 4-butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide |
Synonyms | VVZ-149 Opiranserin 4-butoxy-N-{[4-(dimethylamino)oxan-4-yl]methyl}-3,5-dimethoxybenzamide |
CAS | 1441000-45-8 |
Molecular Formula | C21H34N2O5 |
Molar Mass | 394.51 |
Solubility | Soluble in DMSO |
Storage Condition | -20℃ |
Use | Opiranserin, a non-opioid and non-steroidal anti-inflammatory analgesic, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) with IC50 of 0.86 and 1.3 μM, respectively. Opiranserin has antagonistic effect on rP2X3 (IC50=0.87 μM). |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.535 ml | 12.674 ml | 25.348 ml |
5 mM | 0.507 ml | 2.535 ml | 5.07 ml |
10 mM | 0.253 ml | 1.267 ml | 2.535 ml |
5 mM | 0.051 ml | 0.253 ml | 0.507 ml |